CLINICAL_TRIALS
trial_result
· 2017-06-28
Clinical Trial Update: Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients [Phase 2, Phase 3]
Summary
A Phase 2/3 study evaluated adding sarilumab to methotrexate in rheumatoid arthritis patients; the trial completed and results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-06-28